In a filing, Perspective Therapeutics Inc revealed its Director Williamson Robert F III acquired Company’s shares for reported $22814.0 on Nov 25 ’24. In the deal valued at $3.64 per share,6,266 shares were bought. As a result of this transaction, Williamson Robert F III now holds 430,058 shares worth roughly $1.78 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hunt Jonathan Robert bought 12,829 shares, generating $48,974 in total proceeds. Upon buying the shares at $3.82, the Chief Financial Officer now owns 48,800 shares.
Before that, Spoor Johan M. bought 14,500 shares. Perspective Therapeutics Inc shares valued at $54,868 were divested by the CEO at a price of $3.78 per share. As a result of the transaction, Spoor Johan M. now holds 152,072 shares, worth roughly $0.63 million.
BofA Securities downgraded its Perspective Therapeutics Inc [CATX] rating to a Neutral from a a Buy in a research note published on November 25, 2024; the price target was decreased to $5 from $24. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Wedbush began covering CATX with “an Outperform” recommendation on October 01, 2024. Truist started covering the stock on September 25, 2024. It rated CATX as “a Buy”.
Price Performance Review of CATX
On Monday, Perspective Therapeutics Inc [AMEX:CATX] saw its stock fall -4.60% to $4.15. Over the last five days, the stock has gained 19.60%. Perspective Therapeutics Inc shares have risen nearly 3.23% since the year began. Nevertheless, the stocks have risen 62.75% over the past one year. While a 52-week high of $19.05 was reached on 05/15/24, a 52-week low of $2.28 was recorded on 11/22/24. SMA at 50 days reached $10.60, while 200 days put it at $12.63.
Levels Of Support And Resistance For CATX Stock
The 24-hour chart illustrates a support level at 4.04, which if violated will result in even more drops to 3.93. On the upside, there is a resistance level at 4.32. A further resistance level may holdings at 4.49. The Relative Strength Index (RSI) on the 14-day chart is 24.05, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 85.30%. Stochastics %K at 14.70% indicates the stock is a buying.
How much short interest is there in Perspective Therapeutics Inc?
A steep rise in short interest was recorded in Perspective Therapeutics Inc stocks on 2024-11-15, growing by 0.4 million shares to a total of 8.28 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 7.88 million shares. There was a rise of 4.78%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 25, 2024 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $24 price target.
